A Study of ANAVEX3-71 in Adults With Schizophrenia
Study sponsor: Anavex Life Sciences Corp. · AVXL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-06-30Estimated
Enrollment · participants71Actual
Source updated2025-05-04Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.